DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how ...
Drawbacks to biotech funding or declines in outsourcing penetration rates could have a material impact on Icon's growth. Icon could fail to innovate and keep an edge over regional and global CRO ...
Icon reported strong fourth-quarter results highlighted by revenue of $1.9 billion, representing an increase of 4% from the prior-year period. Full-year revenue of $7.7 billion represented an increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback